tirzepatide and pepto bismol (GLP-2) Research Material Alcohol and Pepto Bismol: Mixing

Important Notes BPC-157 is not FDA-approved for medical treatment Long-term human safety data is limited People with medical conditions should consult a healthcare professional before use Not recommended for pregnant or breastfeeding women Use caution when combining with other performance or recovery compounds

However, even in people without diabetes, optimising natural GLP-1 production may support metabolic health, potentially reduce appetite, and possibly contribute to maintaining insulin sensitivity

Any use of BPC-157 is considered investigational and should only be discussed with a qualified medical provider